This situation has concluded
It was preserved as a record on October 15; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
3 clusters · 8 sources · 19 days · First seen · Last updated
Bayer Roundup litigation and settlement efforts
Overview
Bayer continues to face legal and financial challenges regarding its herbicide Roundup and allegations that its active ingredient, glyphosate, causes non-Hodgkin lymphoma.
In the United States, a Missouri court is conducting a fairness hearing regarding a proposed $7.25 billion settlement. While previous estimates addressed approximately 65,000 claims, the current settlement aims to resolve litigation involving approximately 197,000 Americans. If approved, the deal would provide between $10,000 and $165,000 for affected individuals.
However, the settlement faces opposition from some plaintiffs’ attorneys who have characterized the deal as a ‘collusive arrangement.’ These objectors argue that the framework provides significant fees to attorneys while offering relatively small payouts to victims. They have also criticized the settlement for allowing Bayer to continue selling the product without cancer warnings and for limiting future punitive damages through a 20-year claims period. Bayer maintains that glyphosate is safe and denies all allegations of wrongdoing.
In Chile, the legal battle has taken a different turn. The Supreme Court rejected a cassation appeal by the Organization of Consumers and Users (ODECU), ending a five-year class action lawsuit against Bayer and Arysta LifeScience. Following the dismissal, ODECU has called on Bayer to voluntarily implement compensation and assistance mechanisms for affected individuals, similar to the programs established by the company in the United States.
Entities
Bayer · Monsanto · Roundup · Arysta LifeScience · Timothy Boyer
Claims
What the coverage asserts, and how many sources carry each claim.
- [○ 1 SOURCE] Judge Timothy Boyer called a fairness hearing to address complaints regarding the proposed settlement. www.thenewlede.org
- [○ 1 SOURCE] The proposed settlement for Roundup cancer litigation is valued at $7.25 billion. www.thenewlede.org
- [○ 1 SOURCE] Individual cancer victims could receive between $10,000 and $165,000 under the settlement. www.thenewlede.org
- [○ 1 SOURCE] Approximately 197,000 Americans had filed lawsuits against Bayer. www.it-boltwise.de
- [○ 1 SOURCE] The settlement includes $675 million in fees for the attorneys involved. www.thenewlede.org
- [○ 1 SOURCE] The settlement would allow Bayer to continue selling glyphosate-based weed killers. www.thenewlede.org
Timeline
-
[BUSINESS] 4 sourcesBayer glyphosate settlement faces US court fairness hearing
A Missouri court is reviewing a proposed $7.25 billion settlement by Bayer to resolve Roundup glyphosate litigation involving nearly 200,000 claimants.
-
[BUSINESS] 2 sourcesBayer seeks approval for $7.25 billion Roundup settlement
Bayer seeks court approval for a $7.25 billion settlement to resolve tens of thousands of U.S. lawsuits alleging Roundup causes non-Hodgkin lymphoma, with individual payouts varying by severity.
-
[BUSINESS] 2 sourcesBayer faces calls for voluntary compensation after Chile court rejects Roundup lawsuit
Chile's Supreme Court dismissed a class action lawsuit against Bayer and Arysta regarding Roundup's alleged links to cancer, prompting consumer advocates to call for voluntary compensation models.
Sources
faz.net · finanzen.net · finde.latercera.com · insurancejournal.com · it-boltwise.de · portalfruticola.com · thenewlede.org · thepricer.org
This summary has been updated 1 time: see revision history